[Risk factors of allogeneic red blood transfusion following enhanced recovery hip and knee arthroplasty]
- PMID: 32993246
- DOI: 10.3760/cma.j.cn112137-20200515-01557
[Risk factors of allogeneic red blood transfusion following enhanced recovery hip and knee arthroplasty]
Abstract
Objective: To Explore the current status and risk factors of perioperative allogenic red blood cell transfusion following enhanced recovery hip and knee joint arthroplasty. Methods: Patients who have taken their primary unilateral total hip and knee arthroplasty (THA, TKA) or simultaneous primary THA were retrospectively included from January, 2019 to December, 2019 in West China Hospital. The baseline characteristics were compared between patients with allogeneic transfusion and those without. And logistic regression were used to analyze the risk factors of perioperative allogeneic red blood cell transfusion. Results: A total of 2 034 patients (2072 arthroplasties) were included, 705 males and 1 329 females, aged (60±24) years. Of all, 1 137 patients received primary THA (38 simultaneous THA), 897 patients received primary unilateral TKA. Eleven (0.54%) patients received allogeneic red blood cell transfusion, and the mean volume was (2.6±1.2) U. Deep venous thrombosis occurred in 2 patients (0.09%) undergoing primary TKA. The transfusion rate in primary THA patients was 0.79% (9/1 137), and 0.22% (2/897) in TKA. Lower preoperative hemoglobin level (P=0.041) and more hematological comorbidities (P=0.005) were detected in transfused patients. And logistic analysis further revealed that preoperative substandard hemoglobin level was the most important risk factor for transfusion (OR=5.663, P=0.018). Conclusions: Under the intervention of enhanced recovery after surgery concept and modern blood management strategies, the transfusion requirement has been significantly reduced following primary joint arthroplasty. Pre-operative hemoglobin level should be an important threshold for perioperative blood management.
目的: 探索加速康复关节置换术围术期输血现状及危险因素。 方法: 通过医院病例系统回顾性纳入2019年1至12月于四川大学华西医院骨科行初次髋关节置换术(THA)、膝关节置换术(TKA)的患者数据。对比初次THA及初次TKA患者的输血率及输血与未输血患者之间的差异,同时利用logistic回归分析围术期输血危险因素。主要观察指标是围术期输血率、下肢深静脉血栓发生率。 结果: 共纳入2 034例患者,2 072台初次THA及TKA;男705例,女1 329例;年龄(60±24)岁。其中初次单侧THA患者1 099例,同期双侧THA 38例;初次单侧TKA患者897例。在所有患者中,共有11例(0.54%)在围术期接受了红细胞悬液输注,平均输血量为(2.6±1.2)U;2例(0.09%)TKA术后患者发生下肢深静脉血栓。其中初次THA患者的平均输血率为0.79%(9/1 137),初次TKA患者的输血率为0.22%(2/897)。输血患者术前血红蛋白(Hb)较低(P=0.041),术前并存血液系统疾病的比例更高(P=0.005)。多因素logistic回归分析进一步提示术前Hb未达标是围术期输血的独立危险因素(OR=5.663,P=0.018)。 结论: 在加速康复理念及现代血液管理策略的干预下,初次THA和TKA围术期输血率已显著降低;术前Hb水平达标应是围术期血液管理的重要门槛。.
Keywords: Allogeneic transfusion; Arthroplasty, replacement, hip; Arthroplasty, replacement, knee; Blood management; Enhanced recovery after surgery.
Similar articles
-
[Multivariate analysis of blood loss during primary total hip or knee arthroplasty].Acta Chir Orthop Traumatol Cech. 2013;80(3):219-25. Acta Chir Orthop Traumatol Cech. 2013. PMID: 23777948 Czech.
-
Recent Trends in Blood Utilization After Primary Hip and Knee Arthroplasty.J Arthroplasty. 2017 Mar;32(3):724-727. doi: 10.1016/j.arth.2016.09.026. Epub 2016 Sep 28. J Arthroplasty. 2017. PMID: 27866952
-
Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.J Bone Joint Surg Am. 2014 Feb 19;96(4):279-84. doi: 10.2106/JBJS.L.01041. J Bone Joint Surg Am. 2014. PMID: 24553883
-
Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.Thromb Res. 2017 May;153:28-36. doi: 10.1016/j.thromres.2017.03.009. Epub 2017 Mar 10. Thromb Res. 2017. PMID: 28319822 Review.
-
Factors associated with hospital stay length, discharge destination, and 30-day readmission rate after primary hip or knee arthroplasty: Retrospective Cohort Study.Orthop Traumatol Surg Res. 2019 Sep;105(5):949-955. doi: 10.1016/j.otsr.2019.04.012. Epub 2019 Jun 15. Orthop Traumatol Surg Res. 2019. PMID: 31208932 Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical